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Abstract : Background : The aim of this study was to investigate the influence of obesity and the usefulness of 
a pre-operative weight loss program (PWLP) for obese patients undergoing laparoscopic gastrectomy (LG) for 
gastric cancer (GC). Materials and Methods : Study1 : 219 patients who underwent laparoscopic distal gastrecto-
my (LDG) for GC were divided into 2 groups : body mass index (BMI) ≧ 28 and BMI < 28kg / m2. The influence of 
BMI in LG surgery was investigated. Study2 : The BMI ≧ 28 kg / m2 patients with a planned LG (n = 8) undertook 
a PWLP including calorie restriction and exercise. The effects of this program were evaluated. Results : Study1 : 
The BMI ≧ 28kg / m2 group showed significantly longer operation times, more blood loss and a higher frequency 
of post-operative complications than that of the BMI < 28kg / m2 group. Study 2 : The patients achieved a weight 
loss of 4.2%. The visceral fat area (VFA) was significantly decreased by 10.6%, whereas skeletal muscle mass was 
unaffected. The PWLP group showed shorter operation times, less blood loss and a lower frequency of post-op-
erative complications compared with that of the BMI ≧ 28kg / m2 group. Conclusion : Obesity is an important risk 
factor and a pre-operative weight loss program is useful for obese patients undergoing a LG. J. Med. Invest. 68 : 
165-169, February, 2021
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INTRODUCTION
 
Since laparoscopic gastrectomy (LG) surgery for gastric can-
cer was firstly reported in 1994, the number of patients who have 
undergone a LG has been increasing (1). A LG is reported to 
have some major advantages compared with conventional open 
gastrectomy : less blood loss ; less post-operative pain ; less respi-
ratory dysfunction ; and shorter hospital stays (2, 3).
 However, obesity is one of the important risk factors for 
the manifestation of technical difficulties and post-operative 
complications. Kunisaki, et al. reported that a high body mass 
index (BMI) and a high visceral fat area (VFA) could predict 
technical difficulties and post-operative complications for LG 
surgery (4). Regarding post-operative pancreatic fistula (POPF), 
male patients with a high BMI were identified in uni-variate 
and multi-variate analyses as risk factors associated with POPF 
after a laparoscopic distal gastrectomy (LDG) (5). In this report, 
the POPF group had a high incidence of longer operation times, 
post-operative complications and longer post-operative hospital 
stays. 
The aim of this study was to investigate the influence of 
obesity in LG surgery retrospectively and the usefulness of a 
pre-operative weight loss program (PWLP) for obese patients 
undergoing a LG for gastric cancer (GC) prospectively. 
MATERIALS AND METHODS
Study1 : The influence of BMI in LG surgery
From January 2002 through December 2016, 219 patients 
(167 male and 52 female ; age range from 38- 85 years (mean age 
69.0 years)) were referred to the Tokushima University Hospital 
for the treatment of GC. These 219 patients underwent LDGs. 
Written informed consent was provided by each patient before 
surgery. LDGs with D1 or D1+ lymph node dissection were per-
formed for clinical stage IA cancers and LDGs with D2 dissec-
tion were performed for stage IB, II, III cancers. Staging for all 
the cancers was based on the Japanese Classification of Gastric 
Carcinoma (JCGC) (6). 
In this study, there were two (2) groups : BMI ≧ 28 (BMI ≧ 2
8kg / m2 ; n = 14) ; and < 28kg / m2 (BMI < 28kg / m2 ; n = 205). The 
patients’ backgrounds in both groups are shown in Table 1. 
Study2 : A PWLP for LG surgery
The protocol for this research project was approved by a suit-
ably constituted Ethics Committee of the Tokushima University 
Hospital.
The indication for a PWLP at the Tokushima University Hos-
pital consisted of a BMI ≧ 28 kg / m2, early GC (Tumor depth ; cM 
or cSM) and a planned LG. Written informed consent was pro-
vided by each patient before surgery.
 The exclusion criteria were conditions associated with poor 
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compliance (psychiatric illness).
 The PWLP contained calorie restriction (total 1,200kcalories) 
and exercise (matched age and activities of daily living (ADL)) 
for 10 – 30days. The exercise in the PWLP had standing exer-
cises, leg presses, calf raises, ergometer and self-training in the 
Department of Rehabilitation.
 The primary endpoint was a minimization or exclusion 
of post-operative complications. The secondary endpoints 
were : weight loss ; VFA ; body fat mass ; skeletal muscle ; nutri-
tional parameters ; operative time ; blood loss ; and length of hos-
pital stay. The data regarding VFA, body fat mass and skeletal 
muscle were obtained by the InBody 770®.
 Table 2 showed the characteristics of the patients’ in the 
PWLP. The BMI ≧ 28 kg / m2 patients with a planned LG (n  =  8, 
body weight (BW) 73.1kg, BMI 30.1kg / m2) underwent the 
PWLP. Regarding co-morbidity, there were three (3) patients 
with diabetes, one (1) with renal failure, five (5) with cardiovas-
cular diseases and one (1) using steroid. The mean duration of 
the PWLP was 26.3 (range 19 - 40) days. 
General clinical and clinic-pathological data from each eligi-
ble patient were retrieved from medical reports. All data was 
reviewed retrospectively and the Clavien-Dindo Classification 
was used to compare the short-term complication rate during the 
inpatient hospital stay.
Statistical analysis 
The unpaired / paired Student’s t-test or the Mann–Whitney 
U test were used for the statistical analysis of the continuous 
variables and the χ² test was used for the categorical variables. 
For all three (3) tests, p < 0.05 was interpreted as significant. 
The values for each continuous variable are expressed as a mean 
± the standard deviation (SD).
RESULTS
Study1 : The influence of the BMI in LG surgery
Figures 1a and 1b show the operation times and intra-opera-
tive blood loss in the BMI ≧ 28 and < 28 groups. The BMI ≧ 28 
group had significantly longer operation times and more blood 
loss than the BMI < 28 group. Furthermore, the BMI ≧ 28 
group had a high incidence of post-operative complications (Cla-
vien-Dindo > gradeII) including pancreatic fistula (Figure 1c). 
Regarding post-operative hospital stay, there was no significant 
difference between the two (2) groups (Figure 1d).
Study2 : A PWLP for LG surgery
In Study2, the effects of a PWLP on the BMI ≧ 28 patients for 
planned LG surgery were evaluated.
 The patients achieved a weight loss of 4.2% (-3.1 kg) (Figure 
2a, b). VFA and body fat mass were significantly decreased (VFA 
10.6% ; body fat mass 5.8%) (Figure 2c, d), whereas skeletal mus-
cle mass was unaffected (Figure 2e). 
Total cholesterol and triglyceride counts were decreased (Fig-
ure 3a, b). However, albumin showed no significant difference 
(Figure 3c). Aspartic aminotransferase (AST) and alamine 
aminotransferase (ALT) on post-PWLP examination were sig-
nificantly lower than that on pre-PWLP examination indicating 
that a PWLP might contribute to the improvement of fatty liver 
(Figure 3d, e).
The PWLP group showed shorter operation times, less blood 
loss (Figure 4a, b) and lower frequency of post-operative com-
plications compared with that in the BMI ≧ 28kg / m2 group 
(Figure 4c). Furthermore, this program was correlated with 
shorter post-operative hospital stays compared with that in the 
BMI ≧ 28kg / m2 group (Figure 4d). 
 
DISCUSSION
This study was designed to investigate the influence of obesity 
on LG surgery and the usefulness of a PWLP for obese patients 
undergoing LG surgery for GC. The BMI ≧ 28kg / m2 group 
showed significantly longer operation times, more blood loss and 
a higher frequency of post-operative complications than that in 
the BMI < 28kg / m2 group. The PWLP group achieved a decrease 
of BW and visceral fat mass. This group showed shorter opera-
tion times, less blood loss and lower frequency of post-operative 
complications compared with that in the BMI ≧ 28kg / m2 group. 
 In the authors’ previous report the patients with a high VFA 
(≧ 100cm2) had an increase in the incidence of post-operative 
complications and intra-operative blood loss while the number 
of dissected lymph nodes decreased. On the one hand, the VFA 
was reported to be superior to the BMI as a predictive factor for 
risk with LG surgery for GC (7). On the other hand, Goto, et al. 
reported that the ‘skin-to-celiac artery distance (SCD)’ was a 
simple predictive index for longer operation times during LDG 
surgery (8). Several reports showed the correlation between the 
obesity-related parameters and the risk factors in LG surgery 
such as operation time, blood loss and post-operative complications 
Table 1.　Patients’ characteristics in the BMI≧ 28 and < 28 groups.
Factors BMI≧ 28(n = 14)
BMI < 28
(n = 205) p value
Age (y.o.) 65.4 ± 6.9(51− 83)
69.2 ± 11.3
(38− 85) 0.71
Gender : male / female 10 / 4 157 / 48 0.65
BMI (kg / ㎡ ) 29.2 ± 0.8(28.1− 30.7)
22.5 ± 2.8
(16.6− 27.9) < 0.01
Depth of invasion :
　M, SM / MP / SS / SE 8 / 4 / 2 / 0 139 / 36 / 26 / 4 0.90
Dissection : D1, 1+ / 2 10 / 4 155 / 50 0.75
fStage : I / II, III 12 / 2 177 / 28 0.94
The Mann–Whitney U test was used for the statistical analysis of 
the continuous variables and the χ² test was used for categorical 
variables. P < 0.05 was interpreted as significant. The values for 
each continuous variable are expressed as a mean ± the standard 
deviation (SD).
Table 2.　Patients’ characteristics in the PWLP group.
Factors n = 8
Age (y.o.) 69.8 ± 7.5 (58− 81)
Gender : male / female 6 / 2
BMI (kg / m2) 30.1 ± 7.9 (28.0− 34.8)
Body weight (kg) 73.1 ± 6.3 (58.5− 81.7)
Comorbidity (+ / -) 8 / 0
Duration of PWLP (days) 26.3 ± 6.6 (19− 40)
Operation (LDG / LTG / LPPG) 4 / 3 / 1
fStage (I / II) 7 / 1
The Mann–Whitney U test was used for the statistical analysis of 
the continuous variables and the χ² test was used for categorical 
variables. P < 0.05 was interpreted as significant. The values for 
each continuous variable are expressed as a mean ± the standard 
deviation (SD).
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Figures 1a - 1d.　Comparisons of operation time (1a), blood loss (1b), post-operative complications 
(1c) and post-operative hospital stay (1d) in the BMI≧ 28 and < 28 groups.
The unpaired Student’s t-test was used for the statistical analysis of the continuous variables. 
P < 0.05 was interpreted as significant. The values for each continuous variable are expressed as a 
mean ± the standard deviation (SD).
Figures 2a - 2e.　Comparisons of BW (2a), BMI (2b), VFA (2c), body fat mass (2d) and skeletal 
muscle (2e) pre- and post-PWLP.
The paired Student’s t-test was used for the statistical analysis of the continuous variables. P < 0.05 
was interpreted as significant. The values for each continuous variable are expressed as a mean ± 
the standard deviation (SD).
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Figures 3a - 3e.　Comparisons of total cholesterol (3a), triglyceride (3b), albumin (3c), AST (3d) 
and ALT (3e) pre- and post-PWLP.
The paired Student’s t-test was used for the statistical analysis of the continuous variables. P < 0.05 
was interpreted as significant. The values for each continuous variable are expressed as a mean ± 
the standard deviation (SD).
Figures 4a - 4d.　Comparisons of operation times (4a), blood loss (4b), post-operative complications 
(4c) and post-operative hospital stays (4d) in the PWLP and BMI≧ 28 groups.
The unpaired Student’s t-test was used for the statistical analysis of the continuous variables. 
P < 0.05 was interpreted as significant. The values for each continuous variable are expressed as a 
mean ± the standard deviation (SD).
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including pancreatic fistula.
 For the purpose of improving the operative outcomes, a PWLP 
was started in the Department of Surgery, Tokushima Universi-
ty with the approval of a suitably constituted Ethics Committee 
of Tokushima University Hospital. 
 Regarding bariatric surgery, a pre-operative diet with im-
mune-nutrition formulas achieved a pre-operative weight loss, 
lower post-operative pain and lower CRP and liver enzymes in 
laparoscopic sleeve gastrectomy than high-protein formulas or 
regular diet, all of them with similar caloric intake (9).
 However, one of the important problems in weight loss is the 
incidence of sarcopenia. Decrease of skeletal muscle, referred 
to as sarcopenia, was reported to correlate with the morbidity 
and mortality in the patients undergoing digestive surgery. 
‘Unintentional’ weight loss could be used to predict mortality 
and morbidity rates in colo-rectal surgery. Pre-operative weight 
loss had a significant association with cardiopulmonary com-
plications (10). Kaido. et al. reported that sarcopenia was closely 
related with post-operative mortality in the patients undergoing 
LDLT and peri-operative nutritional intervention was important 
for the survival of patients with sarcopenia (11). ‘Sarcopenic 
obesity’ was defined as the criteria for sarcopenia and obesity 
by body fat mass (male ≧ 25%, female ≧ 35%). Regarding HCC, 
pre-operative sarcopenic obesity was an independent risk factor 
for the survival of the patient and recurrence of the condition 
after operation (12).
 In pre-operative weight loss, the prevention of sarcopenia is 
very important for the decrease of peri-operative complications. 
In this study, the PWLP showed no decrease of skeletal muscle 
with the maintenance of several nutritional factors.
 The progression of GC during the PWLP is one of the im-
portant problems. H.J.F. Brenkman, et al. reported that a longer 
waiting time (even if > 8 weeks) until the start of the gastrec-
tomy surgery for GC was not associated with a worse overall 
survival (13). So, the duration of the PWLP for 19 – 40 days 
might be reasonable for the purpose of decreasing post-operative 
complications.
 In conclusion, obesity is an important risk factor and a PWLP 
is useful for obese patients undergoing LG surgery.
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